Back to the benchmark

Ardenfield Biosciences · AI Readiness result · ABS-5126_01OCT

Wilson Elser

Ardenfield Biosciences

Showing you what AI is telling clinicians, patients, investors and regulators about Ardenfield Biosciences before they speak to you: where that account is sound, where it is exposed, and where the board’s attention is needed due to exposure.

The results show where they stand on the AI Readiness Maturity Scale™, and the gap between what they understand of themselves and what AI sees of them, where they are in terms of fitness for AI Visibility.

Assessed

02 OCT '26

BENCHMARK

Life Sciences

REPORT REF.

ABS-5126_01OCT

aaanow.aiAI Readiness Benchmark

Contents

What AI sees of you,
set against what you know of yourself.

First, what AI sees of Ardenfield Biosciences and why it matters. Then, where it stands among the 75 organisations in its sector.

What AI sees

03

Summary

How likely AI is to answer incorrectly about Ardenfield Biosciences.

04

The root cause

Where most misinformation starts: the organisation’s own content.

05

Your AI Readiness

Fitness for visibility on the main website, and why it matters.

06

Digital Doorway

Whether AI can reach the website at all.

The sector

07

The sector chart

Where Life Sciences stands on the AI Readiness maturity scale.

08

Risk across the sector

How likely AI is to repeat something incorrect.

09

The organisations included

The 75 organisations in the rankings.

AI READINESS · FITNESS FOR VISIBILITY| 2
Wilson Elser

Summary

31%AI ANSWERS AT RISK

Results · Ardenfield Biosciences

1 in 4 AI answers about Ardenfield Biosciences are likely to be incorrect
or misleading.

That is the account clinicians, patients, investors and regulators receive before they speak to you. It is drawn from the PDFs and web pages you have published, and from the site build that carries them.

ABS-5126_01OCT · ARDENFIELD BIOSCIENCES| 3
Wilson Elser

MISINFORMATION, ACROSS ALL WEBSITES

AAAnow Research, Dec. 2023 to Jan. 2026; P&C (human misinformation) 2014 to 2023.

79%OWN CONTENT

Misinformation · where it starts

Most misinformation starts with the organisation's own content: old material AI still finds and repeats.

Digital leaders have been saying so for years. Control now and you advance further, faster, while others deal with the impact of misinformation. Your organisation is more efficient, and your value grows faster: that is the AI advantage.

AI READINESS · FITNESS FOR VISIBILITY| 4
Wilson Elser

AI READINESS · MAIN WEBSITE · FITNESS FOR VISIBILITY

Your AI Readiness

Why it matters

Where you are today. Each reading shows how far the published documents, the web pages and the site that carries them can be relied on by AI, with 100 the strongest position.

CONTENT INFRASTRUCTURE73%
PDF pages58%
Web pages72%

When clinicians, patients, investors and regulators use AI to assess your organisation, they form their view from the information it presents.

Where that information is incomplete, out of date or misread, the view is wrong before a conversation begins, and confidence in the organisation, and the decisions taken about it, follow that view.

AI Readiness shows where weaknesses in the published information leave the organisation exposed, seen from the outside in, as AI sees it. That lets the board decide what needs correcting and direct resource to the information that bears on decisions about the organisation. AI is already using what is available; the question is whether what it finds is appropriate.

ABS-5126_01OCT · Ardenfield Biosciences| 5
Wilson Elser

Digital Doorway · ARDENFIELD BIOSCIENCES

First: can AI see you?

Digital Doorway

Checking what AI can see is part of AI Readiness (content infrastructure). It starts with your main website (findings below) and extends to your full landscape.

WHAT CAN AI SEE? 22 ROUTES, 2 FAILING

If AI cannot see you, what you publish counts for nothing. Blocking AI is the root of misinformation: denied the source, AI forms its own version of the organisation and repeats it.

Blocking is not always known. It may be something the organisation set up itself, for its own reasons, or a change made by a service provider on its behalf. Without monitoring, you do not know it has happened.

All too common: the main website is closed to AI while historic assets nobody manages remain open. AI is fed what is out of date, and those unknown assets undermine you continually.

ABS-5126_01OCT · ARDENFIELD BIOSCIENCES| 6
Wilson Elser

The sector · Life Sciences

75 sites around a ring, each a spoke. The further a dot sits from the centre, the higher its AI readiness, from 20 to 100 percent. Stages run clockwise from the top: ACT 55, OPTIMISE 11, MONITOR 3, then 6 sites BLOCKED, where the AI connection was refused and no reading was possible.20–50%50–75%75–100%75SITES

The sector, as AI sees it.

How AI reads a sector shapes how that sector is understood. For a board, knowing where the sector stands, and where your organisation sits within it, is the understanding that decisions on AI are built on.

This month

Since last month

55ACT

AI struggles to read what
these sites publish.

NAup

NAdown

11OPTIMISE

Foundations in place,
with gaps to close.

NAup

NAdown

3MONITOR

The strongest position.
The task is to build on it.

NAdown

6BLOCKED

AI connection refused, local AI
Agents access prevented or
website was not available
AI READINESS · FITNESS FOR VISIBILITY| 7
Wilson Elser

The sector · Risk profile

AI Misinformation risk across the sector

What AI repeats about an organisation is formed from what the organisation itself publishes. Where that material is outdated, inconsistent or hard for AI to read, AI fills the gap, and the difference between what the organisation knows of itself and what AI presents becomes misinformation.

1site15sites29sites24sitesCONCENTRATION: 53 OF 69 SITESTHE EXCEPTIONThe only site where AIis likely to be accurateLOW RISKAI is likely to surfaceaccurate information.ELEVATED RISKSome of what AI repeats islikely to be incorrect.HIGH RISKAI Misinformation risk,resulting in ongoing exposure.SEVERE RISKAI is very likely to repeatsomething incorrect.6 BLOCKEDAI access refused, so no reading waspossible and AI forms its own version.
AI READINESS · FITNESS FOR VISIBILITY| 8
Wilson Elser

The sector · the organisations included

The 75 organisations, included in the rankings.

01Abbott LaboratoriesUS
02AbbVieUS
03AbCelleraCanada
04Advanced Medical SolutionsUK
05AmgenUS
06Animalcare GroupUK
07AnsellAustralia
08ApotexCanada
09argenxNetherlands
10AstraZenecaUK
11Aurinia PharmaceuticalsCanada
12Australian Clinical LabsAustralia
13Bausch + LombCanada
14Bausch HealthCanada
15BayerGermany
16BioNTechGermany
17BioSyentCanada
18Boehringer IngelheimGermany
19Bristol Myers SquibbUS
20Cipher PharmaceuticalsCanada
21Clinuvel PharmaceuticalsAustralia
22CochlearAustralia
23ConvatecUK
24CSLAustralia
25DanaherUS
26Eli Lilly and CompanyUS
27GenmabDenmark
28GenusUK
29Gilead SciencesUS
30GSKUK
31HaleonUK
32HealiusAustralia
33Hikma PharmaceuticalsUK
34ImmunocoreUK
35Integral DiagnosticsAustralia
36Jamieson WellnessCanada
37Johnson & JohnsonUS
38Knight TherapeuticsCanada
39LivaNovaUK
40LonzaSwitzerland
41Mayne PharmaAustralia
42Medexus PharmaceuticalsCanada
43MedtronicIreland
44Merck & Co.US
45Merck KGaAGermany
46MesoblastAustralia
47ModernaUS
48NanosonicsAustralia
49Neuren PharmaceuticalsAustralia
50NIOX GroupUK
51NovartisSwitzerland
52Novo NordiskDenmark
53Oncolytics BiotechCanada
54Oxford BiomedicaUK
55Oxford Nanopore TechnologiesUK
56PfizerUS
57PolyNovoAustralia
58Pro MedicusAustralia
59Profound MedicalCanada
60Regeneron PharmaceuticalsUS
61RocheSwitzerland
62SandozSwitzerland
63SanofiFrance
64Siemens HealthineersGermany
65Smith+NephewUK
66Sonic HealthcareAustralia
67StrykerUS
68Telix PharmaceuticalsAustralia
69TheratechnologiesCanada
70Thermo Fisher ScientificUS
71TristelUK
72UCBBelgium
73Vertex PharmaceuticalsUS
74Xenon PharmaceuticalsCanada
75ZymeworksCanada

The population assessed: 75 current organisations, 15 in each of 5 regions: the United States, the United Kingdom, the European Union and Switzerland, Canada and Australia.

AI READINESS · FITNESS FOR VISIBILITY| 9
Wilson Elser

Your contacts at Wilson Elser

Supporting clients
and their boards as AI advances.

We work alongside life sciences organisations and their boards. Where directors and officers may have been left exposed by what AI says about the organisation, they advise on the board’s position.

Specialist advice is offered for regulatory, medical affairs and legal teams on the advances of AI and what each means for compliance.
Portrait of Adam R. Bialek

Adam R. Bialek

Partner · New York, NY

Co-chair of the Intellectual Property and Technology Practice. Counsels on internet law, digital compliance, data security and website accessibility.

[email protected]

Portrait of Jana S. Farmer

Jana S. Farmer

Partner · White Plains, NY

A leader of the Privacy, Security and AI practice (CIPP/US, AIGP, FIP). Advises on cookie and tracking compliance, consent and AI governance, and defends privacy claims.

[email protected]

AI READINESS · FITNESS FOR VISIBILITY| 10

What follows

From the result,
to the decisions it informs.

So far, what AI sees of Ardenfield Biosciences. Next, what that can lead to, the counsel available, and what it asks of the board.

What can happen

12

Feeding AI created compliance failures

Outdated product information, given by AI as the current one.

13

Annual report, compounding misinformation

A misread figure, repeated to the market, shareholders and regulators.

FOR THE EXECUTIVE TO REVIEW

14

Board oversight

Existing duties, a new place to apply them.

The AAAnow service

15

Who we are, and what we do

AI Discovery, AI Accelerator and AI Confidence, each building on the last.

16

The monthly board summary

An example of the result the board receives each month.

AI READINESS · FITNESS FOR VISIBILITY| 11
Wilson Elser

WHAT CAN HAPPEN - CREATING LIABILITIES

Feeding AI created compliance failures

Example use case, where a life sciences firm was feeding a new 'AI-enabled' medical information service with outdated product documents. Confusion aggregated by content that was already available online.

YOUR DOCUMENTS

THE REVISION

READ BY AI

AT THE POINT OF USE

THE EXPOSURE

THE BOARD

01

Product information as PDFs, several versions, no version handling.

02

Dosing and safety information revised and published correctly.

03

AI weighs the old and new PDFs and serves the original as current.

04

Staff, clinicians and patients act on withdrawn dosing and safety information.

05

Wrong dosing, wrong safety advice, details provided by the firm; we now have 'compliance' liabilities.

06

Directors' accountability and insurance cover in question.

Directors and Officers personal liabilities

Insurance (D&O / Organisation cover) implications

All life sciences use cases: aaanow.ai/use-cases/life-sciences/Life sciences, the use casesWe do not enable external links - please copy and paste, you are then certain as to the link being opened

AI READINESS · FITNESS FOR VISIBILITY| 12
Wilson Elser

WHAT CAN HAPPEN - COMPOUNDING MISINFORMATION

Annual report, compounding misinformation

The fault in your online annual report is misread by AI and repeated to the market,
shareholders and regulators. Correcting it grows harder at each stage.

YOUR WEBSITE

READ BY AI

AI, REPEATED

THE MARKET

SHAREHOLDERS

REGULATORS

01

Your online annual report with build / structure issues.

02

AI misreads the earnings data within it.

03

AI consolidates the misreading into its account of you.

04

Market feeds, fed by AI, show a negative position.

05

Shareholders are alerted to the issue; they are also seeing the issue if they ask their AI the question.

06

Regulators challenge figures that differ from those reported.

AI READINESS · FITNESS FOR VISIBILITY| 13
Wilson Elser

Board oversight

Existing duties, a new place to apply them.

The account is drawn from your own material.

Clinicians, patients, investors and regulators ask AI before they ask the organisation.

The answer is formed from what the organisation has published, and 1 in 14 AI answers about Ardenfield Biosciences are likely to be incorrect or misread.

Approved figures can lose their meaning after sign-off: a value read against the wrong year, a withdrawn label still found and repeated. The material is the company’s own, and so is the decision to govern it.

The board already has these duties.

Under UK and Delaware law, directors owe reasonable care, skill and diligence, and a good-faith effort to monitor the company’s central risks (Companies Act 2006, s.174; Marchand v Barnhill, 2019).

Exchange rules in New York and London require material information to reach the market promptly and accurately.

Where harm follows, the examination turns to the board: what it knew, and what it did.

The record is the board’s answer.

D&O underwriters are giving closer attention to board oversight and to checks on public disclosures, and policy wording is moving with new exclusions and endorsements (Aon; Gallagher, 2026).

A baseline, recorded corrections and later checks show what the board knew and how it responded. With that record the board can answer an investor, a regulator or an underwriter, and proceed with AI knowing its position.

D&O review - details at https://aaanow.ai/service/ai-governance/

AI READINESS · FITNESS FOR VISIBILITY| 14
AAAnow

The AAAnow service · 3 levels of service

Immediate value, your foundation for AI confidence

A secure service, deployable at scale. It starts with the gap between what your organisation knows of itself
and what AI sees of it, and builds from where you stand today to oversight as you grow.

Landscape mapping

Your sites across the web, found and prioritised: fix or remove, so outdated content stops speaking for you and the cost of carrying it falls.

01

AI Discovery

Light touch: content and capabilities audit, so you understand your fitness for AI visibility before further AI investment.

02

AI Accelerator

The content your AI activity depends on, understood across your organisation and turned into practical action within 6 weeks.

03

AI Confidence

Independent monthly oversight as you advance and grow, keeping ahead of change across your digital landscape. The advantage is yours: you act on what AI sees while others are still finding out, with reporting the board can act on.

AI Governance

Evidence of control over what has been published.

AI READINESS · FITNESS FOR VISIBILITY| 15
AAAnow

AI CONFIDENCE · THE MONTHLY BOARD SUMMARY

33%50%75%100%+16+14+18+9+15+8+17+12+14+6+535SITES

Know your position, lead in AI.

Monthly the board knows where it stands with AI.
That knowledge is your advantage: decisions are made with confidence and with the evidence of control you minimise officers' personal liabilities.

This month

Since last month

25ACT

AI struggles to read what
these sites publish.

8up

6down

8OPTIMISE

Foundations in place,
with gaps to close.

3up

2down

2MONITOR

The strongest position.
The task is to hold it.

1down

AI READINESS · FITNESS FOR VISIBILITY| 16
AAAnow

54 Poland St, Soho,
London. W1F 7NJ.

How the result was measured

Statement of position. These results draw on the AI Readiness audits of 28 SEP '26 and 01 OCT '26. They are the first published results for this benchmark, and they will be reviewed again after the second quarterly benchmark. To our knowledge, no benchmark of AI Readiness, fitness for AI visibility, has been carried out at this scale before. The results are therefore modelled across the 2 sets of findings. The results show how AI systems read, connect and cite an organisation's published information. They do not describe how people read or judge that information.

Disclaimer. Any view given of exposure, for directors and officers or for the organisation, is an opinion formed from these findings. It is not legal advice. Each organisation should carry out its own review and take independent legal advice before acting on it.

EndAAAnow · Confidential

1 of 10